Open original FDA record ↗Recall record
- FDA identifier
- Z-0072-2026
- Company in FDA record
- LeMaitre Vascular, Inc.
- FDA classification date
- Oct 8, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Devices were distributed with incorrect label without CE and UKCA mark, missing patient leaflet and patient implant card.
Source facts
- Action
- LeMaitre Vascular notified consignees on about 08/25/2025 via letter. Consignees were instructed to identify any affected units in inventory, quarantine those affected units, and arrange for their return. If the product has been implanted, graft explantation/patient intervention is not required. Consignees were also instructed to notify all consignees/customers who should be aware and where affected product has been transferred. Consignees were requested to complete and return the Customer Reply Form. Distributors were requested to indicate that they have quarantine affected units in stock and notified all customers who have received the product.
- Initiated
- 2025-08-25
- Root cause
- Process control
- Distribution
- No US distribution. International distribution to Great Britian and Switzerland.
- Recall number
- Z-0072-2026
- Recall status
- Open, Classified
- CDRH record ID
- 215947
- FDA classified
- 2025-10-08
- Recall event number
- 97567